Stimulants

Position on unfair transactions in tobacco sales in expressway rest service areas

Retrieved on: 
Wednesday, October 21, 2020

Such practice has grossly limited sales opportunities for expressway rest service area operators, causing them significant economic losses.

Key Points: 
  • Such practice has grossly limited sales opportunities for expressway rest service area operators, causing them significant economic losses.
  • First, 45% of consumers who do not use products from certain tobacco manufacturers are deprived of their tobacco brand options when visiting expressway rest service areas.
  • In addition, 42.3% of respondents thought negatively about the exclusive sales structure of tobacco in expressway rest service areas.
  • The sales and introduction of multiple brands of tobacco in expressway rest service areas are recognized by their operators as having significant economic value and the need for improvement is agreed upon.

Europe Cocaine Dependence Market and Competitive Landscape Report 2020: Pipeline, Epidemiology, Market Valuations, Drug Sales, Market Forecast, Drug Forecasts, and Market Shares 2016-2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 28, 2020

The "Europe Cocaine Dependence Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Cocaine Dependence Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • The research report Europe Cocaine Dependence Market and Competitive Landscape - 2020, provides comprehensive insights into the Cocaine Dependence pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts the Cocaine Dependence market size and drug sales.
  • Cocaine Dependence pipeline: Find out drugs in clinical trials for the treatment of Cocaine Dependence by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Cocaine Dependence drugs: Identify key drugs marketed and prescribed for Cocaine Dependence in the US, including trade name, molecule name, and company
    Cocaine Dependence market valuations: Find out the market size for Cocaine Dependence drugs in 2019 by countries.

Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

Retrieved on: 
Tuesday, September 15, 2020

The enormous potential of medicines like ketamine, psilocybin and MDMA to treat mental health has some whispering that psychedelics are the next billion dollar industry.

Key Points: 
  • The enormous potential of medicines like ketamine, psilocybin and MDMA to treat mental health has some whispering that psychedelics are the next billion dollar industry.
  • They probably aren't wrong: in 2019, Americans spent $225 billionon mental health services, according to the German statistics database Statista.
  • Oakland, Calif., followed Denver several weeks later and Oregon is trying to get a similar measure on the ballot for 2020.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

Retrieved on: 
Tuesday, September 15, 2020

The enormous potential of medicines like ketamine, psilocybin and MDMA to treat mental health has some whispering that psychedelics are the next billion dollar industry.

Key Points: 
  • The enormous potential of medicines like ketamine, psilocybin and MDMA to treat mental health has some whispering that psychedelics are the next billion dollar industry.
  • They probably aren't wrong: in 2019, Americans spent $225 billionon mental health services, according to the German statistics database Statista.
  • Oakland, Calif., followed Denver several weeks later and Oregon is trying to get a similar measure on the ballot for 2020.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Adamas Announces New Employment Inducement Grant

Retrieved on: 
Friday, September 11, 2020

The stock options and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

Key Points: 
  • The stock options and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.
  • At Adamas our vision is clear to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society.
  • We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.
  • In 2018, Adamas successfully launched GOCOVRI (amantadine) extended-release capsules, the first and only FDA-approved medicine for the treatment of dyskinesia in patients with Parkinsons disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.

KemPharm to Present at Upcoming September Investor Conferences

Retrieved on: 
Wednesday, September 2, 2020

KemPharms prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder.

Key Points: 
  • KemPharms prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder.
  • In addition, KemPharm has received FDA approval for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.
  • For more information on KemPharm and its pipeline of prodrug product candidates visit www.kempharm.com or connect with us on Twitter , LinkedIn , Facebook and YouTube .
  • KemPharm is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2 Study of EMB-001 in Cocaine Use Disorder

Retrieved on: 
Monday, August 31, 2020

Embera NeuroTherapeutics, Inc. , a specialty pharmaceutical company developing novel treatments for cocaine, nicotine and potentially other addictions, today announced that the first subjects have begun dosing of EMB-001 in a Phase 2 study for cocaine use disorder.

Key Points: 
  • Embera NeuroTherapeutics, Inc. , a specialty pharmaceutical company developing novel treatments for cocaine, nicotine and potentially other addictions, today announced that the first subjects have begun dosing of EMB-001 in a Phase 2 study for cocaine use disorder.
  • The primary efficacy endpoint is abstinence in subjects dosed with EMB-001 versus placebo during the final three weeks of treatment.
  • The Phase 2 study will evaluate the efficacy of EMB-001 in patients with cocaine use disorder, said Bruce McCarthy, M.D., Chief Medical Officer of Embera.
  • The Phase 2 study will provide a significant opportunity to understand the potential of EMB-001 to help people struggling with cocaine addiction.

Analysis on Impact of COVID-19 - Global Legal Cocaine Market 2020-2024 | Evolving Opportunities with Bio-Techne Corp. and Lannett Co. Inc. | Technavio

Retrieved on: 
Thursday, August 27, 2020

The global legal cocaine market size is expected to grow by 1.27 thousand oz as per Technavio.

Key Points: 
  • The global legal cocaine market size is expected to grow by 1.27 thousand oz as per Technavio.
  • View the full release here: https://www.businesswire.com/news/home/20200826005599/en/
    Technavio has announced its latest market research report titled Global Legal Cocaine Market 2020-2024 (Graphic: Business Wire)
    Read the 120-page report with TOC on "Legal Cocaine Market Analysis Report by Application (Surgical and Recreational) and Geography (Europe, North America, APAC, and ROW), and the Segment Forecasts, 2020-2024".
  • In addition, the rising number of countries decriminalizing and legalizing cocaine is anticipated to boost the growth of the legal cocaine market.
  • Therefore, the growing demand for pharmaceutical-grade cocaine is expected to drive the growth of the legal cocaine market significantly during the forecast period.

Worldwide Cocaine Dependence Market and Competitive Landscape to 2024 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 20, 2020

The "Global Cocaine Dependence Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cocaine Dependence Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into the Cocaine Dependence pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following: Cocaine Dependence treatment options, Cocaine Dependence late stage clinical trials pipeline, Cocaine Dependence prevalence by countries, Cocaine Dependence market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Cocaine Dependence pipeline: Find out drugs in clinical trials for the treatment of Cocaine Dependence by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Cocaine Dependence drugs: Identify key drugs marketed and prescribed for Cocaine Dependence in the US, including trade name, molecule name, and company
    Cocaine Dependence market valuations: Find out the market size for Cocaine Dependence drugs in 2019 by countries.

IDenta Corp Makes the News in Brazil

Retrieved on: 
Tuesday, August 18, 2020

IDenta's Field Test Kit was used to identify 704 kg of Cocaine on a mango fruit container for export at Natal port in Brazil by the Brazilian Federal Police ( http://www.tribunadonorte.com.br/noticia/pf-apreende-703-95-quilos-de-co... ).

Key Points: 
  • IDenta's Field Test Kit was used to identify 704 kg of Cocaine on a mango fruit container for export at Natal port in Brazil by the Brazilian Federal Police ( http://www.tribunadonorte.com.br/noticia/pf-apreende-703-95-quilos-de-co... ).
  • IDenta's quick, precise and easy detection test allow law enforcement to do their job with high safety and maximum reliability.
  • Amichai Glattstein, CEO of IDenta, said "In this case, IDenta prevented 704 kg of Cocaine from making its way to Europe from South America.
  • Since 2002, IDenta Corporation, via its subsidiary IDenta Ltd., has been recognized as a worldwide leader in the development of proprietary on-site and Home Diagnostics Drug, Drug Precursor and Explosive detection kits.